Search Results 311-320 of 17120 for nivolumab
... Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. J Blood Med. 2024; 15:29-34 Epub 2024 Jan 24. View PubMed; Kettani ME, Shah K, Farooq H, Li ...
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. Melanoma In-transit Tissue Bank And Molecular Analysis For Personalized ...
This study hopes to determine the levels of bladder cancer-derived extracellular vesicles pre- and post-RC. In-home Versus In-Clinic Subcutaneous Nivolumab ...
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) ... nivolumab in each disease cohort, both across and within tumor biomarker subgroups.
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line ...
... Nivolumab Scottsdale/Phoenix, AZ; Rochester, MN ... The purpose of this study is to evaluate the dose escalation and expansion of RP1 alone and combined with ...
The purpose of this study is to evaluate the safety, tolerability and effectiveness of HBI-8000 when combined with a standard dose and regimen of nivolumab.
... nivolumab for melanoma, lung cancer, and metastatic kidney cancer. And approval for more types of cancer may be on the way. Stephen Ansell, M.D., Ph.D., a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!